Best Vascular, Inc
Form 483 issued July 11, 2025 · Norcross, Georgia
- Inspection
- Jul 8 – Jul 11, 2025
- Investigator
- Nikki S. Bryant
- Observations
- 1
- Pages
- 4
- FEI number
- 3000205626
In short: On July 11, 2025, FDA issued a Form 483 with 1 observation to Best Vascular, Inc in Norcross, Georgia (FEI 3000205626) after an inspection that ran Jul 8 – Jul 11, 2025. The investigator was Nikki S. Bryant. Most observations concern cAPA; the most-cited regulation is 21 CFR 820.100 (corrective and preventive action).
At a glance
1 of 1 observations on this 483 concern capa.
Most cited: 21 CFR 820.100(b) (1×)
What FDA observed
Preview: the opening words of each observation- 01
Corrective and preventive action activities and/or results have…
This inspection in context
Nikki S. Bryant
3 documents · 2022–2025
Cites 820.100(a) (corrective and preventive action) more than any other section. Most of their documents are for sites in Georgia.
The firmBest Vascular, Inc history
All 2 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sOther sites cited under 820.100(b)
See how FDA wrote the same problem up elsewhere.
Questions about this 483
What did FDA find at Best Vascular, Inc?
FDA listed 1 observation on this Form 483, mostly about cAPA. The most-cited regulation is 21 CFR 820.100 (corrective and preventive action). The opening words of each observation are shown on this page.
Who inspected Best Vascular, Inc?
Nikki S. Bryant is named on this Form 483, for the inspection of Jul 8 – Jul 11, 2025. Each investigator has a profile showing what they cite most.
When was Best Vascular, Inc inspected by FDA?
The inspection ran Jul 8 – Jul 11, 2025, and the Form 483 is dated July 11, 2025.
How do I get the full Form 483 for Best Vascular, Inc?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.